DOCSLIB.ORG

Researcher Profiles and Projects

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Researcher Profiles and Projects Researcher profiles and projects Diamantina Institute 2020/2021 Diamantina Institute Undergraduate research MD student research The University of Queensland to focus their efforts on turning projects experience Diamantina Institute (UQDI) is a their scientific discoveries into new UQDI offers various opportunities UQ Medicine is committed to enhancing modern research facility where clinical treatments for diseases including a for undergraduate students to gain the research training and experience for and basic science are used to study variety of cancers, arthritis and other research experience in biomedical students in the Medical Program. cancer, immunolgy and genomic autoimmune diseases. research facilities including Summer and There are a number of ways students medicine. Winter research projects. UQDI focuses on bringing the can incorporate research training and The Institute has a vibrant community discoveries of basic science to the For further information visit experience into their medical degree. patient. di.uq.edu.au/study/undergraduate of over 300 researchers, students and For further information visit: support staff. We have delivered global, We aim to translate the greatest medicine-program.uq.edu.au/research/ world-changing discoveries to humanity, Summer research projects opportunities for research discoveries research-your-medical-degree such as the world’s first cervical into the cause, mechanism, prevention For further information visit: cancer vaccine. and treatment of major disease. medicine.uq.edu.au/research/research- Research higher degree strategy-and-support-office/summer- Based at the Translational Research As part of The University of UQDI is an internationally recognised research-program research facility where clinical and Institute (TRI) beside the Princess Queensland’s prestigious Faculty of medical sciences converge in the Alexandra Hospital, UQDI has strong Medicine, UQDI is committed to making Winter research projects translational research of cancer, disorders clinical interactions and world-class a global difference to health outcomes. facilities that enable researchers to be For further information visit: of immune regulation and genomic medicine.uq.edu.au/research/research- at the forefront of their fields. UQDI’s medicine. For further information visit strategy-and-support-office/winter- position within the TRI allows for a di.uq.edu.au research-projects For more information on starting a Higher much greater collaborative research Degree by Research with us, please visit: environment, allowing our researchers In July of each year UQDI offers a one medicine.uq.edu.au/future-students#qt- week course in advanced immunology. study-foundation-tabs-4 For further information visit: di.uq.edu.au/event/2293/advanced- Key research themes: immunology-course Honours program UQDI hosts honours students enrolled through other schools within the Cancer Immunotherapy Faculties of Science or Medicine at UQ or affiliated Institutions. These include (but are not limited to) the School of Chemistry and Molecular Biosciences, or Genomic medicine Skin and skin cancer the School of Biomedical Sciences at UQ. The Honours Program is a one year full time course. Students must fulfill the prerequisites of the undergraduate Immunity and Faculty/School through which they are Inflammation enrolled. For further information visit: di.uq.edu.au/study/honours Professor Gabrielle Belz Dr Anne-Sophie Bergot Research Field Research Field Transcriptional regulation of immune cell Immunology and pathogenesis of type 1 diabetes development and memory formation in pathogen defence and mucosal immunity Research Synopsis Anne-Sophie is working with Prof. Ranjeny Research Synopsis Thomas on Immunotherapy for type 1 diabetes Our work aims to understand how the immune (T1D). system responds to infections including viruses, bacteria and parasites. We are investigating the use of a liposome based strategy to develop an antigen-specific We are investigating how different types therapy for T1D. Immunologically, it has a dual of immune cells develop, and what factors role of fostering regulatory T cell function and influences their decision to become one type terminating pathogenic T cells. of immune cell or another to mediate long term immune protection. Research Projects • “Analysis of effector and regulatory T cells Understanding how the body deals with E [email protected] in type 1 diabetes” using various genetic, E [email protected] pathogens will give clues about how to enhance P 07 3443 8026 immunological or cell based assays P 07 3443 6946 protective immunity. Our goal is to discover new therapies that boost our immune system to researchers.uq.edu.au/ researchers.uq.edu.au/ protect against infection. researcher/25382 researcher/2335 Research Projects • Identifying novel functions of innate lymphoid cells and NK cells in immune protection • Unravelling the microbome-epithelial-immune interface protecting mucosal surfaces • Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens Associate Professor Antje Blumenthal Dr Andrew Brooks Research Field Research Field Innate immunity and infectious diseases Class I cytokine receptor signalling and HLA-G regulation of inflammation Research Synopsis With resistance to antibiotics on the rise, new Research Synopsis insights into host defence mechanisms that Our research focuses on understanding the control pathogenic bacteria are vital for the mechanisms of cytokine receptor signalling development of novel therapeutic interventions. and how these receptors regulate cell behavior Our research focuses on molecular pathways and functions such as inflammation, blood that are important for the recognition and cell formation, postnatal growth, obesity, and control of bacterial pathogens as well as those lactation. Dysregulated cytokine receptor that orchestrate inflammatory responses during signalling leads to many diseases such as cancer infection. and inflammatory diseases such as liver fibrosis, inflammatory bowel disease, and arthritis. The Students are part of a dynamic research team to development of novel molecules that target maximise their research training and experience. cytokine receptors or their signalling pathways The research employs a series of molecular, cell E [email protected] E [email protected] may lead to important therapeutics for a wide biological and immunological techniques to P 07 3443 6984 P 07 3443 7071 variety of clinically important diseases. define novel molecular and cellular aspects of the researchers.uq.edu.au/ researchers.uq.edu.au/ host response to infection. Research Projects researcher/2366 researcher/1699 Research Projects • Understanding dysregulated cytokine receptor signalling in leukaemia • Innate immune recognition of pathogenic bacteria • Defining the mechanisms of cytokine receptor signalling • Molecular regulation of host anti-microbial defence mechanisms • Developing novel therapeutic peptides targeting cytokine receptors • Defining the mechanism of HLA-G inhibition of NK cell activation Dr Janin Chandra Professor Paul Clarke Research Field Research Field Immunobiology of antigen-presenting cells in Cell cycle control in cancer health and disease Research Synopsis Research Synopsis Paul Clarke is working on the role of cell division Immunotherapy aims to correct a mal- in the development of cancer and in the response functioning immune system to combat a variety of cancer cells to cancer therapies. His research of diseases including cancer, autoimmunity or group investigates the role of tumour suppressors allergies. Many immunotherapy targets have and oncogenes that control mitosis and mitotic been identified and some have been developed cell death. His group study the function of into powerful treatments. Immunotherapy largely proteins in tumour cells using biochemical targets effector T cell responses which are either techniques to identify their post-translational suppressed or falsely activated. Professional modifications (phosphorylation, ubiquitylation) antigen-presenting cells such as dendritic cells and advanced microscopy to analyse their (DCs) play a pivotal role in T cell fates and localisation and stability in live cells. The group are hence a desired immunotherapy target. aim to understand why tumour cells often have E [email protected] E [email protected] Immunotherapy has the potential to effectively abnormal numbers of chromosomes and why P 07 3443 6976 P 07 3443 7990 harness DCs to prime e.g cancer-specific they become resistant to cell death. This work cytotoxic T cell responses or shut-down self- or researchers.uq.edu.au/ will improve our understanding of how cancer researchers.uq.edu.au/ allergen-reactive T cells. My research focusses researcher/2717 develops and will provide new strategies for researcher/17454 on understanding dendritic cell diversity and cancer therapy. fate, and how manipulation of dendritic cells can Research Projects improve disease outcomes. • The role of tumour suppressors in mitosis Research Projects • Control of mitotic cell death • Characterising the diversity of dendritic cells in steady state and disease • The relationship between cellular ageing and cancer • Defining and optimising the mechanisms of action of therapeutic vaccine candidates Professor Riccardo Dolcetti Professor David Evans Research Field Research Field New strategies to improve cancer Genetics of complex traits and diseases; immunotherapy
Load more

Recommended publications
  • Clinical and Translational Science (CTS) Scholars Program (KL2)
    Clinical and Translational Science Scholars Program 2020-2021 1 Institute for Clinical Research Education Clinical and Translational Science Scholars Program Table of Contents Welcome to the Clinical and Translational Science Scholars Program ……………..p# Contact Information Faculty & Staff 4 Multidisciplinary Advisory Committee (MAC) 6 Program Expectations and Overview Expectations for the Scholars 7 Program Requirements 8 Mock Review Sessions 11 Regulatory Requirements Publication Acknowledgment, Other Support and the NIH Biosketch 12 NIH Inclusion Monitoring 14 NIH Prior Approval and Notification – Policies & Procedures 15 Guidelines for KL2 Career Development Funds 17 CITI Modules 22 Association for Clinical and Translational Science (ACTS) Save the Date 24 Program Evaluation Evaluation/Tracking 25 Appendix A: Authorship Agreement form Appendix B: Clinical and Translational Science Fellowship Mentoring Expectations and Contract Appendix C: CTS Scholars Program Purchasing Form 2 Clinical and Translational Science Scholars Program Welcome Welcome to the Institute for Clinical Research Education (ICRE) at the University of Pittsburgh, and to your Clinical and Translational Science (CTS) Scholars Program (KL2). This program, offered by the ICRE and the Clinical and Translational Science Institute (CTSI), provides individualized, competency-based training in rigorous research methodologies for the design and conduct of high-quality translational research. The CTS Scholars Program provides courses, seminars, workshops, and experiential training to build essential translational research skills in team science, leadership, stakeholder engagement, communication, and moving innovations to commercialization. This handbook points you to important information that will help you throughout your time at the ICRE. However, it is likely you will have questions that are not answered here. Do not hesitate to contact any of us to let us know how we can be of help.
    [Show full text]
  • Challenges of T3 and T4 Translational Research | Vukotich, Jr. | Journal Of
    Home About Announcements Current Issue Past Issues Contributors Forum Home > Volume 12, Issue 2, 2016 > Vukotich, Jr. Journal Help Journal of Research Practice Volume 12, Issue 2, Article P2, 2016 CURRENT ISSUE Provocative Idea: Subscribe Challenges of T3 and T4 Translational Research USER Charles J. Vukotich, Jr. School of Medicine, University of Pittsburgh Username Pittsburgh, PA, UNITED STATES Password [email protected] Remember me Abstract JOURNAL CONTENT Search Translational research is a new and important way of thinking about research. It is a major priority of the National Institutes of Health (NIH) in Search Scope the United States. NIH has created the Clinical and Translational Science All Awards to promote this priority. NIH has defined T1 and T2 phases of translational research in the medical field, in order to bring the benefits of Browse scientific results into communities. Current discussions focus on clarifying By Issue the subsequent phases of translational research necessary to achieve the By Author intended social impact of research. This article suggests that T3 translational By Title research could aim at getting research out of the highly controlled environment of the academic health center and into the real world. Likewise, ARTICLE TOOLS it suggests T4 translational research could aim at policy development Abstract through policy analysis and evaluation, cost-benefit analysis, and Print this article surveillance studies. Translational research has challenges beyond definitions. Translational research is incomplete at any level unless Indexing metadata appropriate steps are taken to communicate the results to relevant Email this article (Login stakeholders. It appears that communication is currently suboptimal at all required) levels of translation.
    [Show full text]
  • Career Education and Enhancement for Health Care Research Diversity (CEED) Program Handbook
    Career Education and Enhancement for Health Care Research Diversity (CEED) Program Handbook University of Pittsburgh School of Medicine Institute for Clinical Research Education July 2019 Contents I. Objective ............................................................................................................................................................................ 2 II. Course Components ...................................................................................................................................................... 2 III. Eligibility: ..................................................................................................................................................................... 2 IV. Funding: ........................................................................................................................................................................ 4 V. Academic Policy and Procedures ............................................................................................................................ 5 A. Statute of Limitations .............................................................................................................................................. 5 B. Cross Registration ..................................................................................................................................................... 5 C. Waiver of Requirements .......................................................................................................................................
    [Show full text]
  • Instructions and Template for Creating a Position Description
    POSITION DESCRIPTION Position Title: Research Operations Manager Organisation Unit: Faculty of Medicine, UQ Diamantina Institute Position Number: 3042523 Type of Employment: Fixed Term, Full Time Classification: HEW 7 THE UNIVERSITY OF QUEENSLAND The University of Queensland (UQ) contributes positively to society by engaging in the creation, preservation, transfer and application of knowledge. UQ helps shape the future by bringing together and developing leaders in their fields to inspire the next generation and to advance ideas that benefit the world. UQ strives for the personal and professional success of its students, staff and alumni. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world. UQ ranks in the world’s top universities, as measured by several key independent ranking, including the Performance Ranking of Scientific Papers for World Universities (43), the US News Best Global Universities Rankings (52), QS World University Rankings (47), Academic Ranking of World Universities (55), and the Times Higher Education World University Rankings (60). UQ again topped the nation in the prestigious Nature Index and our Life Sciences subject field ranking in the Academic Ranking of World Universities was the highest in Australia at 20. UQ has an outstanding reputation for the quality of its teachers, its educational programs and employment outcomes for its students. Our students remain at the heart of what we do. The UQ experience – the UQ Advantage – is distinguished by a research enriched curriculum, international collaborations, industry engagement and opportunities that nurture and develop future leaders. UQ has a strong focus on teaching excellence, winning more national teaching excellence awards than any other in the country and attracting the majority of Queensland's highest academic achievers, as well as top interstate and overseas students.
    [Show full text]
  • A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences
    Citation: Clin Transl Sci (2018) 11, 77–84; doi:10.1111/cts.12495 C 2017 ASCPT. All rights reserved ARTICLE The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences Douglas A. Luke1,∗, Cathy C. Sarli2, Amy M. Suiter2, Bobbi J. Carothers1, Todd B. Combs1, Jae L. Allen3, Courtney E. Beers3 and Bradley A. Evanoff4 We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond biblio- metric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in-house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from trans- lational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts. Clin Transl Sci (2018) 11, 77–84; doi:10.1111/cts.12495; published online on 8 September 2017. Study Highlights WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? WHAT THIS STUDY ADDS TO OUR KNOWLEDGE ✔ Most current knowledge on the topic of the value of clin- ✔ This study presents a framework that can be used to ical and translational research focuses on productivity mea- assess or evaluate these processes and outcomes.
    [Show full text]
  • TRANSLATIONAL RESEARCH: ETHICAL CONSIDERATIONS Yiqing Dong University of Puget Sound, [email protected]
    Honors Program Honors Program Theses University of Puget Sound Year 2018 TRANSLATIONAL RESEARCH: ETHICAL CONSIDERATIONS Yiqing Dong University of Puget Sound, [email protected] This paper is posted at Sound Ideas. https://soundideas.pugetsound.edu/honors program theses/28 Running head: TRANSLATIONAL RESEARCH Translational Research: Ethical Considerations Honors Thesis Yiqing Dong University of Puget Sound TRANSLATIONAL RESEARCH 2 Abstract Translational research (TR) is a new categorization for the efforts of biomedical research and emphasizes efficiency in achieving population health improvements through the application of basic science knowledge in clinical practice. It will be argued that the current emphasis on speed and collaboration with industry established by national policies provides challenges to maintaining the integrity of scientific research. There is no agreed upon definition of TR and the current standard of judging the success of TR focuses on product production. I propose that the principles of beneficence and responsive justice should be used to inform the values of TR and to produce an agreed upon definition for TR. I will also suggest possible actions and changes to help incorporate the principles of beneficence and responsive justice into the translational framework that include greater reflection throughout the translational process about its priorities, increased role of implementation research, and the communication of negative results in addition to positive results. Introduction No agreed upon definition of translational research (TR) exists currently. However, TR encompasses activities from basic laboratory science to the application of knowledge gained from the lab in clinical settings to improve population health. The term first appeared in the 1990s in relation to the discovery of cancer related genes.
    [Show full text]
  • Evaluation Guidelines for the Clinical and Translational Science Awards (Ctsas)
    Special Reports Evaluation Guidelines for the Clinical and Translational Science Awards (CTSAs) William M. Trochim , Ph.D. 1 , Doris M. Rubio , Ph.D. 2 , Veronica G. Thomas , Ph.D. 3 , and the Evaluation Key Function Committee of the CTSA Consortium Abstract The National Center for Advancing Translational Sciences (NCATS), a part of the National Institutes of Health, currently funds the Clini- cal and Translational Science Awards (CTSAs), a national consortium of 61 medical research institutions in 30 states and the District of Columbia. The program seeks to transform the way biomedical research is conducted, speed the translation of laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train a new generation of clinical and translational researchers. An endeavor as ambitious and complex as the CTSA program requires high-quality evaluations in order to show that the program is well implemented, effi ciently managed, and demonstrably effective. In this paper, the Evaluation Key Function Committee of the CTSA Consortium presents an overall framework for evaluating the CTSA program and offers policies to guide the evaluation work. The guidelines set forth are designed to serve as a tool for education within the CTSA community by illuminating key issues and practices that should be considered during evaluation planning, implementation, and utilization. Additionally, these guidelines can provide a basis for ongoing discussions about how the principles articulated in this paper can most effectively be translated into operational reality. Clin Trans Sci 2013; Volume 6: 303–309 Keywords: evaluation , translational research , CTSA Introduction Translational research is a critically important endeavor in appropriate evaluative data and assessment systems, it would contemporary biomedical research and practice.
    [Show full text]
  • Kristen B. Rosati
    Kristen B. Rosati Partner Coppersmith Brockelman PLC [email protected] Direct: (602) 381-5464 Cell (602) 391-4997 2800 North Central Ave., Suite 1200 Phoenix, Arizona 85004 Kristen has deep experience in all things “Big Data,” including HIPAA compliance and data breaches, health information exchange, data sharing for research and clinical integration initiatives, clinical research compliance, clinical trials contracting, and biobanking and genomic privacy. Kristen Rosati is a Past President of the American Health Lawyers Association (AHLA), the nation's largest educational organization devoted to legal issues in the healthcare field with almost 15,000 members. She currently serves on the planning committees for the AHLA’s Academic Medical Centers and Teaching Hospitals Institute and its Precision Medicine Institute. Kristen has been listed in Best Lawyers in America for health care since 2007 and was Best Lawyers’ 2017 and 2014 Phoenix Health Care Law “Lawyer of the Year.” She was chosen as one of Outstanding Business Women in Arizona in 2017 and one of the 50 Most Influential Women in Arizona Business in 2013. She received the Health Care Leadership Award for Legal Advocate of the Year in 2014, and was recognized in Arizona Business Leaders 2015- 2017 and Arizona’s Top 100 Lawyers in 2014- 2017 by Arizona Business Magazine. She has been recognized in Super Lawyers and Chambers for health care. Kristen is an advisor to the FDA Sentinel Initiative, an effort to create a national electronic distributed network to monitor medical product safety. Kristen leads the legal work for Arizona Health-e Connection, Arizona’s health information exchange, and was a member of the National Governor’s Association State Alliance for e-Health, Health Information Protection Task Force.
    [Show full text]
  • Pennsylvania and the Value of NIH Funding
    National Institutes of Health BY THE NUMBERS: is the nation’s primary medical research agency, supporting research efforts in all 50 states and the District of Columbia. PENNSYLVANIA IN FY 2012* $1.460 Billion: NIH funds awarded “This [NIH] funding will allow us to expand novel (From FY 2003-12, NIH funding in research concepts that we have been developing Pennsylvania totaled $14 billion) to develop a broadly effective seasonal influenza 99: NIH-funded institutions vaccine to protect our population.” 3,369: NIH grants awarded David Weiner, PhD, University of 15**: Cong. districts with NIH grants Pennsylvania School of Medicine * http://report.nih.gov/award/ IMPROVING PENNSYLVANIA’S HEALTH THROUGH NIH FUNDING The University of Pennsylvania received $457 million in NIH grants in FY 2012. Basic science research at the university helped develop the breast cancer drug Herceptin, extending the lives of patients with advanced breast cancer and lowering cancer recurrence rates. NIH also supports research at the University of Pittsburgh, which was awarded $430 million in FY 2012. University investigators developed a biodegradable artery graft that, 90 days after being inserted into rats, is completely replaced by a naturally regenerated artery. Children’s Hospital of Philadelphia ranked second in the U.S. News and World Report Best Children's Hospitals Honor Roll 2012-13 and received $126 million in NIH funding in FY 2012. Researchers discovered 25 new genetic copy number variants associated with autism. Pennsylvania State University and the university’s Hershey Medical Center received NIH grants totaling $111 million in FY 2012. Hershey scientists identified a human protein that the malaria parasite uses to infect cells, which could lead to a vaccine or new therapies.
    [Show full text]
  • Translational Research Institute
    CASE STUDY Translational Research Institute This collaboration among four institutions brought Australian scientists together to turn leading- edge research into medical innovations and spur economic growth. Executive Summary Organization Translational Research Institute Location Brisbane, Queensland, Australia Construction Type Australia New construction Opening Date 2012 Project Area 32,000 square meters (344,445 square feet) Total Budget A$354 million The Atlantic Philanthropies Investment A$50 million ($32.2 million) The Translational Research Institute (TRI) in Brisbane, Australia To integrate the interests of all partners, a project control group with brings together more than 650 staff members from four institutions representatives from each institution consolidated user inputs and to focus on biomedical research with direct clinical application. The developed a design reflecting a shared vision. The group ultimately idea for TRI originated from the development of the first cancer- selected an approach that emphasized seamless connections within the preventing vaccine at the University of Queensland—a discovery building. Despite a complicated construction process, TRI became with the potential to save millions of lives and generate billions of fully operational in 2012, on time and under budget. dollars for Australia. However, a lack of infrastructure and industry Today, TRI is known as the first “bench-to-bedside” facility in partnerships stalled commercialization of the vaccine for over a Australia and has elevated the nation’s appreciation for the value of decade. This delay brought national attention to the need to translate translational research. The distinctive appearance of the TRI building research findings into meaningful health outcomes at a time when the has attracted top biomedical researchers to Brisbane.
    [Show full text]
  • Download Download
    © Journal of Interdisciplinary Studies in Education ISSN: 2166-2681 Volume 2, Issue 2, 2014 ittc-web.astate.edu/ojs Conceptualizing the NET: The Neuroeducation Translational (NET) Research Model – A Framework for Neuroscience Research to Special Education Practice Sagarika Kosaraju, Mary Ann Gorman, Katherine Berry George Washington University ABSTRACT Advances in neuroscience related to developmental disorders could substantially impact individuals with disabilities and the field of special education. However, several challenges impede the current translation of neuroscience research for special education practice, such as misinterpretations of neuroscience findings. An investigation of translational research in medicine and social sciences revealed a common conceptual framework founded by the National Institutes of Health (NIH). Using this model as a guide, the authors introduce a new framework, the Neuroeducation Translational (NET) Research Model, to scaffold neuroscience research from the laboratory to special education practice in four phases. Potential benefits to developing a framework for neuroeducation include improved outcomes for individuals with disabilities and knowledge sharing across disciplines. Keywords: neuroeducation, neuroscience research, special education, transdisciplinary, translational research al., 2011). Findings suggest that emotions Researchers in neuroscience are now may affect all aspects of learning, including exploring how cognition, motivation, behavior memory, attention, decision-making, and and other brain processes are connected to social functioning (Bechara, 2005; Damasio, learning (Basset et al., 2011; Howard-Jones, 2005; Gazzaniga, Ivry, & Mangum, 2009; 2010). Advances in brain imaging have Goswami, 2008; Immordino-Yang, 2008; confirmed that the brain is plastic into Immordino-Yang & Damasio, 2007). adulthood, and neural pathways can change Research in neuroscience may have based on environmental experiences (Chiao & profound implications for individuals with Immordino-Yang, 2013; Giedd, 2009; Gogtay disabilities.
    [Show full text]
  • Example Projects from 2019
    EXAMPLE PROJECTS ONLY This is a sample of some of the projects that were offered in 2019 This list is provided to give you an idea of the types of projects that can be conducted during the Foundations of Medical Research (MEDI7281) selective course in Semester 2, Year 2 of the MD. These specific projects may not be available in 2020. An updated list of projects offered in 2020 will be provided in April! If you would like to suggest a supervisor, please contact Dr Megan Steele: [email protected] Project ID: 2095057 Title of project: Investigating prognostic biomarkers in breast cancer Supervisor/s: Dr Peter Simpson Organisational unit / Institute / Centre: UQ Centre for Clinical Research Location: UQ Centre for Clinical Research, Building 71/918, Royal Brisbane and Women’s Hospital, Herston Qld 4029, Field of research: breast cancer, pathology Type of research: Laboratory research Keywords: breast cancer Project overview: This project will investigate the promise of several protein biomarkers in predicting the prognosis of breast cancer patients diagnosed with invasive lobular carcinoma. The proposed biomarkers were identified through a bioinformatic process using publicly available molecular data (gene expression and DNA copy number) and hence need to be validated in an independent cohort of cases. Validation will be done in tissue samples using immunohistochemistry. The students will gain experience in optimising experimental condition; in using microscopy and digital microscopy to visualise and score staining patterns; and in statistical analysis for data analysis to correlate expression of the biomarker(s) with clinical and pathological features (eg breast cancer specific survival).
    [Show full text]